CENT — Q3 FY2026 Financial Report Analysis

Sales fell 8% because Central sold a low-margin business; what's left grew and earned more per dollar

Central Garden & Pet's fiscal third quarter (the three months to June 27, 2026 — the company's fiscal year ends in late September) looks weaker than it is. Net sales dropped $78.5 million, or 8.2%, to $882.4 million, and GAAP net income fell 5.4% to $89.9 million. But almost all of the sales decline came from one deliberate decision: in April 2026 Central contributed its pet distribution business — which resold other manufacturers' pet products to stores and brought in $474 million of sales in fiscal 2025 — into a new partnership with distributor Phillips Pet Food & Supplies, keeping a 20% stake. Strip that out (along with last year's UK exit and the December 2025 Champion acquisition) and "organic" sales — sales from businesses owned in both periods — rose 2.4%, from $842 million to $862 million. The distribution business carried thin margins, so losing it pushed gross margin up 130 basis points (1.3 percentage points) to 35.9%.

At a glance

• Organic sales +2.4% ($862M vs $842M): the reported 8% drop is a portfolio change, not shrinking demand; Garden grew 2.9% and Pet's organic sales grew 1.7%.
• Gross margin 35.9%, up from 34.6%: each dollar of sales now keeps more profit after production costs, because the low-margin resale business is gone and cost-cutting landed in both segments.
• Full-year guidance raised to non-GAAP EPS of "$2.85 or better" (from "$2.70 or better"): management now expects more profit for fiscal 2026 than it did three months ago, with only the seasonally weak fourth quarter left.

The numbers

Operating margin is the share of sales left after paying for products, staff, warehouses and marketing, before interest and tax. Non-GAAP figures are the company's own adjusted numbers, which exclude facility-closure and business-exit costs, tariff refunds and the gain on the distribution deal (explained below).

Pet: smaller, but more profitable per dollar

Pet net sales fell $92.0 million, or 18.7%, to $400.5 million, which the 10-Q attributes entirely to "the divestiture of our pet distribution business in April 2026." Sales of other manufacturers' products — the distribution business — fell $89.2 million. Pet operating income dropped 12.3% to $66.8 million, but most of that gap is one-off costs: Pet absorbed $13.0 million of charges for "the exit of a minor business and the closure of two facilities." On the company's adjusted basis, Pet operating margin jumped to 19.0% from 15.8%, helped by a 330-basis-point rise in gross margin and a $19.5 million cut in selling and administrative costs, "all of which were primarily impacted by the divestiture."

One detail worth noting: Pet's own-brand product sales were down $2.8 million in the quarter, so the 1.7% organic growth figure depends on which exited and acquired businesses are stripped out. Over nine months the picture is firmer — Pet organic sales rose 3.3%, which the filing attributes to its Dog & Cat and wild bird feed businesses.

Garden: the stronger half of the quarter

Garden is highly seasonal — about 64% of its annual sales land in the January–June quarters, when retailers stock up for spring — so the third quarter is its peak. Garden net sales rose $13.5 million, or 2.9%, to $481.9 million, which the filing says came from "wild bird feed, controls and grass seed businesses, primarily volume-based increases from increased retailer listings" (more shelf space at retailers). That was partly offset by losing distribution of a third-party product line: Garden's own-brand sales rose $21.8 million while other manufacturers' products fell $8.3 million. Garden operating income rose $7.1 million to $90.1 million, and its operating margin improved to 18.7% from 17.7%. Selling costs went up — more advertising, plus higher delivery costs from higher volume and fuel surcharges — but the volume growth more than covered them.

Corporate costs ate part of the gain

Unallocated corporate expense rose $7.0 million, or 28.9%, to $31.0 million, "due primarily to higher third-party provider expenses, driven by M&A activity," plus payroll for "data improvement and AI readiness." Pet's $9.4 million drop and Garden's $7.1 million gain netted to only -$2.3 million, so the higher corporate bill accounts for most of the $9.3 million fall in consolidated operating income, even though both segments widened their margins. Some of the M&A spending relates to TRIXIE (below), so part of it should not recur once that deal closes.

Takeaway: Central is swapping volume for margin on purpose. Exiting distribution took about $90 million out of quarterly Pet sales but lifted adjusted Pet operating margin by 3.2 points, and the guidance raise to $2.85-or-better shows the smaller company is on course to earn more for the year than management expected three months ago.

What the headline numbers hide

• The GAAP-to-adjusted gap is mostly closure costs. GAAP net income of $89.9 million becomes $95.6 million adjusted after adding back $13.8 million of facility-closure and exit charges (mostly Pet) and taking out a $3.6 million tariff refund and the $2.5 million gain on the distribution deal (both pre-tax). The refund is for tariffs imposed under the International Emergency Economic Powers Act that courts deemed unconstitutional — real cash, but not repeatable, so the company is right to exclude it. Closure charges, however, show up almost every quarter: $3.9 million a year ago, $8.0 million in the first half of this year, $13.8 million now ($21.7 million year to date). Investors should treat a slice of them as an ongoing cost of reshaping the business, not purely one-off.
• Cash conversion is good. Operating cash flow for the nine months was $207.6 million, up from $149.8 million, against nine-month net income of $176.1 million — about 1.2 dollars of cash per dollar of profit. The press release puts third-quarter operating cash flow alone at $327 million, the seasonal inflow as spring receivables get collected. Cash reached $996.7 million against $1.2 billion of debt; net leverage (debt minus cash, relative to earnings) is just 0.5x.
• Working capital looks healthy. Receivables fell to $460.2 million from $522.7 million a year ago (-12%) and inventory to $631.6 million from $722.1 million (-13%), both falling faster than sales (-8%). Part of the inventory drop is the roughly $69 million of inventory handed over with the distribution business, so it is not all efficiency.
• Buybacks did little this quarter. Diluted share count fell about 1% (61.9 million vs 62.6 million), which is why EPS fell slightly less than net income (-4.6% vs -5.4%). Buybacks slowed sharply: $28.8 million in nine months versus $154.7 million a year ago, conserving cash ahead of TRIXIE. The tax rate (24.7% vs 25.1%) and lower interest expense ($7.8 million vs $8.8 million) were small helps.
• Over nine months the trend is up, not down. Nine-month GAAP EPS is $2.84 vs $2.69 and adjusted EPS $3.04 vs $2.79, on 3.3% organic growth. The third-quarter decline mainly reflects the first full quarter without the distribution business.

A big European purchase is coming

After quarter-end, on July 27, Central agreed to buy 80% of TRIXIE, a German pet supplies and pet snacks company, for about €340 million in cash at closing plus up to €60 million of earn-out (extra payments if TRIXIE hits 2026 performance targets). The remaining ~20% owners can require Central to buy their shares after at least three years. The press release says TRIXIE sells to over 30,000 pet stores, about 90% own-brand, and would take Central to roughly 10% of sales from outside the US. Closing is expected in the first half of fiscal 2027, subject to regulatory approval. With nearly $1 billion of cash, Central can pay for it without new borrowing, but it would be a large foreign integration for a company that wound down its UK operations only last year.

Outlook

Management raised fiscal 2026 non-GAAP diluted EPS guidance to "$2.85 or better" from "$2.70 or better," citing "continued margin discipline, ongoing investment in growth initiatives, and portfolio optimization," and assuming a "competitive and promotional retail environment, a value-oriented consumer, existing tariffs, and inflation in select commodities." It excludes further tariff refunds and any further acquisitions or restructuring. Capital spending stays at about $50 million ($34 million spent so far).

Since nine-month adjusted EPS is already $3.04, the $2.85 floor implies the fourth quarter (July–September) could lose up to about $0.19 per share on an adjusted basis. That fits the seasonal pattern: in fiscal 2025, full-year operating income of $250 million was below the nine-month figure of $256.4 million, meaning last year's fourth quarter ran an operating loss of about $6 million as Garden enters its off-season. The guidance therefore looks conservative unless the fourth quarter is unusually weak. Things to watch in the fiscal 2026 annual results (expected around late November): whether Pet's organic growth holds without distribution volume, whether facility-closure charges finally fade, how much corporate M&A cost recurs, and the first fiscal 2027 guidance that includes TRIXIE.

This is the first Central Garden & Pet report on this site, so there is no earlier outlook to check against.